ARCHIVES

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

This article is from The Cancer Letter archive.

Vol. 20 No. 12 | March 23, 1994

Download PDF Visit The Full Archive

Related Articles

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

Nutrition Program Announcement Lists Suggested Areas For Research

September 22, 1978

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

Tobacco Research Council Awards Six New Grants

July 4, 1975

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975